Umbilical Cord Blood Breakthroughs - Time for Cord Blood Stocks?

Cord blood is blood that comes from umbilical cords, and contains a significant amount of hematopoietic stem cells. Specialized cord blood banks are available to store this blood. Cord blood stem cells are considered far superior to stem cells from bone marrow. Parents often have their newborn's cord blood preserved in the event it may be needed at some point in the future for treatment of their child's or the child's sibling's cancer or genetic disease.

Numerous diseases have been treated with cord blood. As an example, several years ago, The Fred Hutchinson Cancer Center in Seattle, Washington made a major breakthrough in the use of umbilical cord blood to treat blood cancers such as leukemia. The discovery dramatically decreases the recovery time of white blood cells.

Even the U.S. House of Representatives recently passed a bill to extend the federal cord blood program. For additional information on cord blood and how it is collected, stored, and used, go to CordBloodStocks.com.

The cord blood industry is significant and continues to grow. Even Richard Branson, of Virgin Records and Virgin America (VA) fame, is in the cord blood business, setting up Virgin Health, a cord blood bank.

Investors can choose either the cord blood banks or the companies that use cord blood to develop cures. Here are some stocks that participate in the cord blood business. Be aware that some of these companies have low market caps and are very speculative.

Baxter International Inc. (BAX) makes blood collection bags for umbilical cord blood and develop adult stem-cell therapies. They also own a patent for assembling and methods to process cord blood in a sterile fashion to avoid exposure to bacterial contamination and to disburse the introduction of cryopreservation solution into cord blood at a desired rate, thereby avoiding damage or trauma to the cord blood cells. The stock has a PE ratio of 9 and pays a yield of 1.3%.

PerkinElmer, Inc. (PKI) owns ViaCell, a Cambridge, Massachusetts company which sells ViaCord, a product which is used to preserve baby's umbilical cord blood. They also research and other therapeutic uses of umbilical cord blood-derived and adult-derived stem cells. The stock has a PE of 34 and a yield of 0.6%.

Celgene (CELG) This New Jersey company is involved in the discovery, production, and marketing of therapies designed to treat cancer and immune-inflammatory-related diseases. They own LifeBank USA, a cord blood bank. The P/E is 47.6.

Amgen Inc. (AMGN) is also funding research into cord blood extraction, preservation, and storage. The stock has a PE of 20.4 and a yield of 2.1.

Cryo-Cell International (CCEL) This is a Florida based cord blood stem cell bank, specializing in the family market. The stock has a PE ratio of 92.

ThermoGenesis (KOOL) This California company designs, makes, and sells automated blood processing systems for the manufacture, preservation, and delivery of cell therapies. They are involved in a joint venture with GE Healthcare, a unit of General Electric Company (GE) to distribute the AXP[TM] AutoXpress Platform, a closed and automated system for harvesting mononuclear cells from cord blood. They have recently generated negative earnings.

Cord Blood America Inc. (CBAI) One of the cord blood bankers, this Los Angeles company is involved in the collection, testing, processing, and preservation of the blood from umbilical cords for use in future stem cell therapy. They own the Cord Partners umbilical cord blood banking company. They have recently generated negative earnings. The price to earnings ratio is 2.0.

For a free downloadable Excel database of cord blood and stem cell stocks, go to WallStreetNewsNetwork.com.

Disclosure: Author didn't own any of the above at the time the article was written.

By Stockerblog.com

Stocks Going Ex Dividend the Second Week of March

Here is our latest update on the stock trading technique called 'Buying Dividends,' also commonly referred to as 'Dividend Capture.' This is the process of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend. This technique generally works only in bull markets, and can work in flat or choppy markets, but you need to avoid the technique during bear markets.

In order to be entitled to the dividend, you have to buy the stock before the ex-dividend date, and you can't sell the stock until after the ex date. The actual dividend may not be paid for another few weeks. WallStreetNewsNetwork.com has compiled a downloadable and sortable list of the stocks going ex dividend in the near future. The list contains many dividend paying companies, lots with market caps over $500 million, and yields over 2%. Here are a few examples showing the stock symbol, the ex-dividend date, and the yield.

Ameren Corp	AEE	3/9/2015	3.8%
Baxter International	BAX	3/9/2015	3.0%
Cott Corporation	COT	3/9/2015	2.6%
CSG Systems International, Inc.	CSGS	3/9/2015	2.3%
General Motors Company	GM	3/9/2015	3.2%
Laclede Group	LG	3/9/2015	3.5%
Parkway Properties  REIT	PKY	3/9/2015	4.2%

The additional ex-dividend stocks can be found at wsnn.com. (If you have been to the website before, and the latest link doesn't show up, you may have to empty your cache.) If you like dividend stocks, you should check out some of the other high yield stock lists at WallStreetNewsNetwork.com or WSNN.com. Most of the lists are free. 
Dividend definitions:

Declaration date: the day that the company declares that there is going to be an upcoming dividend.

Ex-dividend date: the day on which if you buy the stock, you would not be entitled to that particular dividend; or the first day on which a shareholder can sell the shares and still be entitled to the dividend.

Monthly Dividend Stock List
Record date: the day when you must be on the company's books as a shareholder to receive the dividend. The ex-dividend date is normally set for stocks at two business days before the record date.

Payment date: the day on which the dividend payment is actually made, which can be as long at two months after the ex date.

Book now available: Buying Dividends Revised and Expanded

Book now available: Stock Market Trivia Makes a Great Gift!

Don't forget to reconfirm the ex-dividend date with the company before implementing this technique.

Disclosure: Author did not own any of the above at the time the article was written.

By Stockerblog.com

Stocks Going Ex Dividend the First Week of September

  

Here is our latest update on the stock trading technique called 'Buying Dividends,' also commonly referred to as 'Dividend Capture.' This is the process of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend. This technique generally works only in bull markets, and can work in flat or choppy markets, but you need to avoid the technique during bear markets.

In order to be entitled to the dividend, you have to buy the stock before the ex-dividend date, and you can't sell the stock until after the ex date. The actual dividend may not be paid for another few weeks. WallStreetNewsNetwork.com has compiled a downloadable and sortable list of the stocks going ex dividend in the near future. The list contains many dividend paying companies, lots with market caps over $500 million, and yields over 2%. Here are a few examples showing the stock symbol, the ex-dividend date, and the yield.

Kronos Worldwide Inc	KRO	9/2/14	3.8%
SPDR Series Trust	SIPE	9/2/14	2.7%
Suncor Energy	SU	9/2/14	2.7%
Analog Devices	ADI	9/3/14	2.9%
Arthur J. Gallagher & Co.	AJG	9/3/14	3.1%
AMC Entertainment Holdings Inc	AMC	9/3/14	3.4%
American National Bankshares	AMNB	9/3/14	4.2%
American National Insurance	ANAT	9/3/14	2.7%
Baxter International	BAX	9/3/14	2.8%

 The additional ex-dividend stocks can be found at wsnn.com. (If you have been to the website before, and the latest link doesn't show up, you may have to empty your cache.) If you like dividend stocks, you should check out some of the other high yield stock lists at WallStreetNewsNetwork.com or WSNN.com. Most of the lists are free. 
Dividend definitions:

Declaration date: the day that the company declares that there is going to be an upcoming dividend.

Ex-dividend date: the day on which if you buy the stock, you would not be entitled to that particular dividend; or the first day on which a shareholder can sell the shares and still be entitled to the dividend.

Monthly Dividend Stock List
Record date: the day when you must be on the company's books as a shareholder to receive the dividend. The ex-dividend date is normally set for stocks at two business days before the record date.

Payment date: the day on which the dividend payment is actually made, which can be as long at two months after the ex date.

Book now available: Buying Dividends Revised and Expanded

Book now available: Stock Market Trivia
A Great Gift!

Don't forget to reconfirm the ex-dividend date with the company before implementing this technique.

Disclosure: Author did not own any of the above at the time the article was written.

By Stockerblog.com

Top Cord Blood Stocks

Recently, a doctor who was diagnosed with leukemia was saved with a cord blood transplant. The doctor was an obstetrician who was unable to find a matching bone marrow donor.

Cord blood comes from the umbilical cords of babies, and contains a large amount of hematopoietic stem cells. Specialized cord blood banks store this blood. Cord blood stem cells are considered far superior to stem cells from bone marrow. The cord blood of a baby is preserved in the event it may be needed at some point in the future for treatment of possible cancer or genetic disease of the child or the child's siblings. Numerous diseases have been treated with cord blood. Information on cord blood and how it is collected, stored, and used, is available at CordBloodStocks.com.

Investors have a few options when investing in the cord blood industry. They can own the stocks of the cord blood banks, they can own the companies that use cord blood to develop cures, or they can own companies that produce extraction and storage products. WallStreetNewsNetwork.com has come up with a list of 20 companies involved in the cord blood field.

One example is PerkinElmer, Inc. (PKI), which owns ViaCell, a Cambridge, Massachusetts company which sells ViaCord, a product which is used to preserve baby's umbilical cord blood. They also research and develop other therapeutic uses of umbilical cord blood-derived and adult-derived stem cells. The stock trades at 32 times trailing earnings and sports a yield of 0.6%.

Perkinelmer, Inc - Stock Price and Volume | FindTheBest

Baxter International Inc. (BAX) makes blood collection bags for umbilical cord blood and develop adult stem-cell therapies. They also own a patent for assembling and methods to process cord blood in a sterile fashion to avoid exposure to bacterial contamination and to disburse the introduction of cryopreservation solution into cord blood at a desired rate, thereby avoiding damage or trauma to the cord blood cells. The stock has a trailing price to earnings ratio of 21 and pays a generous yield of 2.8%.

Baxter International Inc - Stock Price and Volume | FindTheBest

Celgene (CELG) is a New Jersey company that is involved in the discovery, production, and marketing of therapies designed to treat cancer and immune-inflammatory-related diseases. They own LifeBank USA, a cord blood bank. The stock has a trailing PE of 28.

Celgene Corporation - Stock Price and Volume | FindTheBest

Amgen Inc. (AMGN) is also funding research into cord blood extraction, preservation, and storage. The stock has a trailing PE of 20 and carries a yield of 2.0%.

Amgen Inc - Stock Price and Volume | FindTheBest

For a free list of cord blood and stem cell stocks, which can be downloaded, updated, and sorted, go to WallStreetNewsNetwork.com.

Disclosure: Author did not own any of the above at the time the article was written.

By Stockerblog.com

Cord Blood May Have Saved a Baby from Brain Damage: Top Cord Blood Stocks

A baby who had a stroke in utero, was treated with her own cord blood at Duke University. The cord blood had been stored from birth by a private cord blood bank. The director of the pediatric program at Duke believes that the cord blood cells help decrease inflammation in the section of the brain that was affected by stroke.

Cord blood is blood that comes from the umbilical cords of babies, and contains a significant amount of hematopoietic stem cells. Specialized cord blood banks store this blood. Cord blood stem cells are considered far superior to stem cells from bone marrow. Cord blood of a baby is preserved in the event it may be needed at some point in the future for treatment of possible cancer or genetic disease of the child or the child's siblings. Numerous diseases have been treated with cord blood. Information on cord blood and how it is collected, stored, and used, is available at CordBloodStocks.com.

Investors have a few options when investing in the cord blood industry. They can own the stocks of the cord blood banks, they can own the companies that use cord blood to develop cures, or they can own companies that produce extraction and storage products. WallStreetNewsNetwork.com has come up with a list of 20 companies involved in the cord blood field.

One example is PerkinElmer, Inc. (PKI), which owns ViaCell, a Cambridge, Massachusetts company which sells ViaCord, a product which is used to preserve baby's umbilical cord blood. They also research and other therapeutic uses of umbilical cord blood-derived and adult-derived stem cells. The stock trades at 30 times earnings and pays a small yield of 0.6%.

Baxter International Inc. (BAX) makes blood collection bags for umbilical cord blood and develop adult stem-cell therapies. They also own a patent for assembling and methods to process cord blood in a sterile fashion to avoid exposure to bacterial contamination and to disburse the introduction of cryopreservation solution into cord blood at a desired rate, thereby avoiding damage or trauma to the cord blood cells. The stock has a price to earnings ratio of 18 and sports a generous yield of 2.9%.

Celgene (CELG) is a New Jersey company that is involved in the discovery, production, and marketing of therapies designed to treat cancer and immune-inflammatory-related diseases. They own LifeBank USA, a cord blood bank. The stock has a PE of 46.

Amgen Inc. (AMGN) is also funding research into cord blood extraction, preservation, and storage. The stock has a forward PE of 19 and carries a decent yield of 2.0%.

For a free list of cord blood and stem cell stocks, which can be downloaded, updated, and sorted, go to WallStreetNewsNetwork.com.

Disclosure: Author did not own any of the above at the time the article was written.

By Stockerblog.com

Stocks Going Ex Dividend the First Week of September 2012

  Here is our latest update on the stock trading technique called 'Buying Dividends'. This is the process of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend. This technique generally works only in bull markets. In flat or choppy markets, you have to be extremely careful, and may need to avoid the technique during those times.

In order to be entitled to the dividend, you have to buy the stock before the ex-dividend date, and you can't sell the stock until after the ex date. The actual dividend may not be paid for another few weeks. WallStreetNewsNetwork.com has compiled a downloadable and sortable list of the stocks going ex dividend during the next week or two. The list contains many dividend paying companies, all with market caps over $500 million, and yields over 2%. Here are a few examples showing the stock symbol, the ex-dividend date, the yield, and the market capitalization.


Kimberly Clark Corp (KMB) 9/5/12 3.5% $33.0B Baxter International Inc. (BAX) 9/5/12 3.1% $32.1B Public Service Enterprise Group Inc. (PEG) 9/5/12 4.4% $16.3B Nedbank Group Ltd. ADR (NDBKY) 9/5/12 3.8% $10.1B Genuine Parts Company (GPC) 9/5/12 3.1% $9.9B SLM Corp (SLM) 9/5/12 3.2% $7.4B Gannett Co., Inc. (GCI) 9/5/12 5.2% $3.6B Kronos Worldwide, Inc. (KRO) 9/5/12 3.5% $2.0B American National Insurance Company (ANAT) 9/5/12 4.4% $1.9B

The additional ex-dividend stocks can be found at wsnn.com. (If you have been to the website before, and the latest link doesn't show up, you may have to empty your cache.) If you like dividend stocks, you should check out the high yield utility stocks and the Monthly Dividend Stocks at WallStreetNewsNetwork.com or WSNN.com.

Dividend definitions:

Declaration date: the day that the company declares that there is going to be an upcoming dividend.

Ex-dividend date: the day on which if you buy the stock, you would not be entitled to that particular dividend; or the first day on which a shareholder can sell the shares and still be entitled to the dividend.

Monthly Dividend Stock List
Record date: the day when you must be on the company's books as a shareholder to receive the dividend. The ex-dividend date is normally set for stocks two business days before the record date.

Payment date: the day on which the dividend payment is actually made, which can be as long at two months after the ex date.

Buying Dividends (Dividend Capture) book 25% Off
Don't forget to reconfirm the ex-dividend date with the company before implementing this technique.

Disclosure: Author did not own any of the above at the time the article was written.

By Stockerblog.com

Cord Blood May Treat Strokes and Spinal Cord Injuries

Salk Institute for Biological Studies researchers have discovered the use of a single protein called transcription factor-to convert cord blood cells may be helpful in treating spinal cord injuries, strokes, and other neurological disorders. Other research has shown that umbilical cord blood may be useful in treating leukemia. Several companies, both large and small, are involved in the cord blood industry, and Richard Branson has even invested in the cord blood business.

Cord blood is blood that comes from the umbilical cords of babies, and contains a significant amount of hematopoietic stem cells. Specialized cord blood banks store this blood. Cord blood stem cells are considered far superior to stem cells from bone marrow. Cord blood of a baby is preserved in the event it may be needed at some point in the future for treatment of the cancer or genetic disease of the child or the child's siblings. Many diseases have been treated with cord blood. Information on cord blood and how it is collected, stored, and used, is available at CordBloodStocks.com.

Investors have two options when investing in this industry. They can own the stocks of the cord blood banks or own the companies that use cord blood to develop cures and produce extraction and storage products. WallStreetNewsNetwork.com has come up with a list of 20 companies involved in the cord blood field. One example is PerkinElmer, Inc. (PKI), which owns ViaCell, a Cambridge, Massachusetts company which sells ViaCord, a product which is used to preserve baby's umbilical cord blood. They also research and other therapeutic uses of umbilical cord blood-derived and adult-derived stem cells. The stock trades at 11 times forward earnings and pays a decent yield of 1.1%.

Baxter International Inc. (BAX) makes blood collection bags for umbilical cord blood and develop adult stem-cell therapies. They also own a patent for assembling and methods to process cord blood in a sterile fashion to avoid exposure to bacterial contamination and to disburse the introduction of cryopreservation solution into cord blood at a desired rate, thereby avoiding damage or trauma to the cord blood cells. The stock has a forward price to earnings ratio of 11.4 and sports a yield of 2.4%.

Celgene (CELG) is a New Jersey company that is involved in the discovery, production, and marketing of therapies designed to treat cancer and immune-inflammatory-related diseases. They own LifeBank USA, a cord blood bank. The stock has a forward PE of 12.3.

Amgen Inc. (AMGN) is also funding research into cord blood extraction, preservation, and storage. The stock has a forward PE of 11.6 and carries a yield of 1.9%.

For a free list of cord blood and stem cell stocks, which can be downloaded, updated, and sorted, go to WallStreetNewsNetwork.com.

Disclosure: Author did not own any of the above at the time the article was written.

By Stockerblog.com

Many Cord Blood Companies Experiencing Double Digit Growth

A report called 'Capitalizing on Opportunities in Cord Blood Industry Growth' was just released by MarketResearch.com, which describes how a certain sector of blood banks are experiencing a very fast growth rate, ranging from 17% per year to 25% per year. The 201 page report is available for download for $3,995. This industry has got the attention of billionaires, such as Richard Branson, of Virgin Records and Virgin Atlantic Airways fame. He created Virgin Health, a cord blood bank.

So what is cord blood? Cord blood is blood that comes from the umbilical cords of babies, and contains a significant amount of hematopoietic stem cells. Specialized cord blood banks store this blood. Cord blood stem cells are considered far superior to stem cells from bone marrow. Cord blood of a baby is preserved in the event it may be needed at some point in the future for treatment of the cancer or genetic disease of the child or the child's siblings. Many diseases have been treated with cord blood. Information on cord blood and how it is collected, stored, and used, is available at CordBloodStocks.com.

Investors have two options when investing in this industry. They can own the stocks of the cord blood banks or own the companies that use cord blood to develop cures and produce extraction and storage products. One that falls into the second category is PerkinElmer, Inc. (PKI), which owns ViaCell, a Cambridge, Massachusetts company which sells ViaCord, a product which is used to preserve baby's umbilical cord blood. They also research and other therapeutic uses of umbilical cord blood-derived and adult-derived stem cells. The stock trades at 10 times forward earnings and pays a decent yield of 1.5%.

Baxter International Inc. (BAX) makes blood collection bags for umbilical cord blood and develop adult stem-cell therapies. They also own a patent for assembling and methods to process cord blood in a sterile fashion to avoid exposure to bacterial contamination and to disburse the introduction of cryopreservation solution into cord blood at a desired rate, thereby avoiding damage or trauma to the cord blood cells. The stock has a forward price to earnings ratio of 10 and sports a yield of 2.7%.

Celgene (CELG) is a New Jersey company that is involved in the discovery, production, and marketing of therapies designed to treat cancer and immune-inflammatory-related diseases. They own LifeBank USA, a cord blood bank. The stock has a forward PE of 14.

Amgen Inc. (AMGN) is also funding research into cord blood extraction, preservation, and storage. The stock has a forward PE of 10 and carries a yield of 2.0%.

China Cord Blood Corporation (CO) provides cord blood collection, and stem cell storage services. The company is based in Beijing, China. The stock trades at 9 times earnings.

For a free list of cord blood and stem cell stocks, which can be downloaded, updated, and sorted, go to WallStreetNewsNetwork.com.

Disclosure: Author did not own any of the above at the time the article was written.

By Stockerblog.com

U of Colorado Opens Cord Blood Bank: What About Cord Blood Stocks

University of Colorado recently opened a public cord blood bank, funded by the federal government. Donations are accepted from almost anyone and the cord blood is available to those in need.

Cord blood is blood that comes from the umbilical cords of babies, and contains a significant amount of hematopoietic stem cells. Specialized cord blood banks, both private and public, are available to store this blood. Cord blood stem cells are considered far superior to stem cells from bone marrow. Parents often have their baby's cord blood preserved in the event it may be needed at some point in the future for treatment of their child's or the child's sibling's cancer or genetic disease. Numerous diseases have been treated with cord blood. For a lot more detail on cord blood and how it is collected, stored, and used, go to CordBloodStocks.com.

The cord blood industry continues to grow. Even Richard Branson, of Virgin Records and Virgin Atlantic Airways fame, set up Virgin Health, a cord blood bank. Investors have a two-pronged approach to this investment industry: owning the stocks of the cord blood banks or owning the companies that use cord blood to develop cures.

PerkinElmer, Inc. (PKI) owns ViaCell, a Cambridge, Massachusetts company which sells ViaCord, a product which is used to preserve baby's umbilical cord blood. They also research and other therapeutic uses of umbilical cord blood-derived and adult-derived stem cells. The stock trades at 12 times forward earnings and pays a yield of 1.3%.

Baxter International Inc. (BAX) makes blood collection bags for umbilical cord blood and develop adult stem-cell therapies. They also own a patent for assembling and methods to process cord blood in a sterile fashion to avoid exposure to bacterial contamination and to disburse the introduction of cryopreservation solution into cord blood at a desired rate, thereby avoiding damage or trauma to the cord blood cells. The stock has a forward price to earnings ratio of 12 and pays a yield of 2.3%.

Celgene (CELG) is a New Jersey company that is involved in the discovery, production, and marketing of therapies designed to treat cancer and immune-inflammatory-related diseases. They own LifeBank USA, a cord blood bank. The forward PE is 14, but does not pay a dividend.

Amgen Inc. (AMGN) is also funding research into cord blood extraction, preservation, and storage. The stock has a forward PE of 10 and sports a yield of 2.1%.

China Cord Blood Corporation (CO) provides cord blood collection, and stem cell storage services. The company is based in Beijing, China. The stock does not pay a dividend but trades at 12 times earnings.

For a free list of cord blood and stem cell stocks, which can be downloaded, updated, and sorted, go to WallStreetNewsNetwork.com.

Disclosure: Author did not own any of the above at the time the article was written.

By Stockerblog.com

Top Cord Blood Stocks

The University of South Florida Department of Neurosurgery and Brain Repair just published the results of their research showing that after stroke-like damage, human umbilical cord blood cells protect astrocytes (animal cells) from cell death when deprived of oxygen.

Cord blood is blood that comes from umbilical cords, and contains a significant amount of hematopoietic stem cells. Specialized cord blood banks are available to store this blood. Cord blood stem cells are considered far superior to stem cells from bone marrow. Parents often have their newborn's cord blood preserved in the event it may be needed at some point in the future for treatment of their child's or the child's sibling's cancer or genetic disease. Numerous diseases have been treated with cord blood. For a lot more detail on cord blood and how it is collected, stored, and used, go to CordBloodStocks.com.

The cord blood industry is a fast growing industry, and includes the likes of Richard Branson, of Virgin Records and Virgin Atlantic Airways fame, who set up Virgin Health, a cord blood bank.

Investors have the option of owning the cord blood banks or the companies that use cord blood to develop cures (or both). Here are some stocks that participate in the cord blood business. Be aware that some of these companies have low market caps and are very speculative.

Baxter International Inc. (BAX) makes blood collection bags for umbilical cord blood and develop adult stem-cell therapies. They also own a patent for assembling and methods to process cord blood in a sterile fashion to avoid exposure to bacterial contamination and to disburse the introduction of cryopreservation solution into cord blood at a desired rate, thereby avoiding damage or trauma to the cord blood cells. The stock has a PE ratio of 17 and pays a yield of 2.6%.

PerkinElmer, Inc. (PKI) owns ViaCell, a Cambridge, Massachusetts company which sells ViaCord, a product which is used to preserve baby's umbilical cord blood. They also research and other therapeutic uses of umbilical cord blood-derived and adult-derived stem cells. The stock has a PE of 19 and a yield of 1.4%.

Celgene (CELG) This New Jersey company is involved in the discovery, production, and marketing of therapies designed to treat cancer and immune-inflammatory-related diseases. They own LifeBank USA, a cord blood bank. The P/E is 27.

Amgen Inc. (AMGN) is also funding research into cord blood extraction, preservation, and storage. The stock has a PE of 11.

China Cord Blood Corporation (CO) provides cord blood collection, and stem cell storage services.The company is based in Beijing, China. The stock has a PE of 40 and a forward PE of 20.

The following stocks are extremely low cap stock and should therefore be considered extremely speculative.

Cryo-Cell International (CCEL.OB) This is a Florida based cord blood stem cell bank, specializing in the family market. The stock has a PE ratio of 10.

ThermoGenesis (KOOL) This California company designs, makes, and sells automated blood processing systems for the manufacture, preservation, and delivery of cell therapies. They are involved in a joint venture with GE Healthcare, a unit of General Electric Company (GE) to distribute the AXP[TM] AutoXpress Platform, a closed and automated system for harvesting mononuclear cells from cord blood. They have recently generated negative earnings.

Cord Blood America Inc. (CBAI.OB) One of the cord blood bankers, this Los Angeles company is involved in the collection, testing, processing, and preservation of the blood from umbilical cords for use in future stem cell therapy. They own the Cord Partners umbilical cord blood banking company. They have recently generated negative earnings.

For a free list of cord blood and stem cell stocks, which can be downloaded and sorted, go to WallStreetNewsNetwork.com.

Author does not own any of the above.

By Stockerblog.com

Umbilical Cord Blood Breakthrough for Treating Leukemia

The Fred Hutchinson Cancer Center in Seattle, Washington made a major breakthrough in the use of umbilical cord blood to treat blood cancers such as leukemia. The discovery dramatically decreases the recovery time of white blood cells.

Cord blood is blood that comes from umbilical cords, and contains a significant amount of hematopoietic stem cells. Specialized cord blood banks are available to store this blood. Cord blood stem cells are considered far superior to stem cells from bone marrow. Parents often have their newborn's cord blood preserved in the event it may be needed at some point in the future for treatment of their child's or the child's sibling's cancer or genetic disease. Numerous diseases have been treated with cord blood. For a lot more detail on cord blood and how it is collected, stored, and used, go to CordBloodStocks.com.

The growth of the cord blood industry is substantial. Even Richard Branson, of Virgin Records and Virgin Atlantic Airways fame, is in the cord blood business, setting up Virgin Health, a cord blood bank.

Investors can choose either the cord blood banks or the companies that use cord blood to develop cures. Here are some stocks that participate in the cord blood business. Be aware that some of these companies have low market caps and are very speculative.

Baxter International Inc. (BAX) makes blood collection bags for umbilical cord blood and develop adult stem-cell therapies. They also own a patent for assembling and methods to process cord blood in a sterile fashion to avoid exposure to bacterial contamination and to disburse the introduction of cryopreservation solution into cord blood at a desired rate, thereby avoiding damage or trauma to the cord blood cells. The stock has a PE ratio of 17 and pays a yield of 1.9%.

PerkinElmer, Inc. (PKI) owns ViaCell, a Cambridge, Massachusetts company which sells ViaCord, a product which is used to preserve baby's umbilical cord blood. They also research and other therapeutic uses of umbilical cord blood-derived and adult-derived stem cells. The stock has a PE of 33 and a yield of 1.3%.

Celgene (CELG) This New Jersey company is involved in the discovery, production, and marketing of therapies designed to treat cancer and immune-inflammatory-related diseases. They own LifeBank USA, a cord blood bank. The P/E is 72.

Amgen Inc. (AMGN) is also funding research into cord blood extraction, preservation, and storage. The stock has a PE of 12.

Cryo-Cell International (CCEL.OB) This is a Florida based cord blood stem cell bank, specializing in the family market. The stock has a PE ratio of 10. This is an extremely low cap stock and should therefore be considered extremely speculative.

ThermoGenesis (KOOL) This California company designs, makes, and sells automated blood processing systems for the manufacture, preservation, and delivery of cell therapies. They are involved in a joint venture with GE Healthcare, a unit of General Electric Company (GE) to distribute the AXP[TM] AutoXpress Platform, a closed and automated system for harvesting mononuclear cells from cord blood. They have recently generated negative earnings. This is an extremely low cap stock and should therefore be considered extremely speculative.

Cord Blood America Inc. (CBAI.OB) One of the cord blood bankers, this Los Angeles company is involved in the collection, testing, processing, and preservation of the blood from umbilical cords for use in future stem cell therapy. They own the Cord Partners umbilical cord blood banking company. They have recently generated negative earnings. This is an extremely low cap stock and should therefore be considered extremely speculative.

For a free downloadable Excel database of cord blood and stem cell stocks, go to WallStreetNewsNetwork.com.

Author does not own any of the above.

By Stockerblog.com

Cord Blood Stocks

Cord blood has been in the news a lot recently. A Florida hospital is waiving the fee for the donation of cord blood. Five cord blood transfer centers in Spain have joined a study for the treatment of lymphoma and leukemia. And a cord blood bank in Texas has added Midland Memorial Hospital to is collection network.

Cord blood is blood that comes from umbilical cords, and contains an extensive amount of hematopoietic stem cells. The blood is kept in depositories called blood banks. Cord blood stem cells are considered far superior to stem cells from bone marrow. Many parents have their newborn's cord blood preserved in the event it may be needed at some point in the future for treatment of their child's or the child's sibling's cancer or genetic disease. Over 75 diseases have been treated with cord blood. For a lot more detail on cord blood and how it is collected, stored, and used, go to CordBloodStocks.com.

Even Richard Branson, of Virgin Records and Virgin Atlantic Airways fame, is in the cord blood business. He set up Virgin Health, a cord blood bank.

There are a couple ways to invest in the cord blood industry, the cord blood banks and the companies that use cord blood to develop cures. Here are several stocks that participate in the cord blood business. Please be aware that many of these companies have low market caps and are extremely speculative.

Cord Blood America Inc. (CBAI.OB) One of the cord blood bankers, this Los Angeles company is involved in the collection, testing, processing, and preservation of the blood from umbilical cords for use in future stem cell therapy. They own the Cord Partners umbilical cord blood banking company. They have recently generated negative earnings. This is an extremely low cap stock and should therefore be considered extremely speculative.

ThermoGenesis (KOOL) This California company designs, makes, and sells automated blood processing systems for the manufacture, preservation, and delivery of cell therapies. They are involved in a joint venture with GE Healthcare, a unit of General Electric Company (GE) to distribute the AXP(TM) AutoXpress Platform, a closed and automated system for harvesting mononuclear cells from cord blood. They have a price sales ratio of 1.4. They have recently generated negative earnings. This is an extremely low cap stock and should therefore be considered extremely speculative.

Cryo-Cell International (CCEL.OB) This is a Florida based cord blood stem cell bank, specializing in the family market. The stock has a PE ratio of 665. This is an extremely low cap stock and should therefore be considered extremely speculative.

PerkinElmer, Inc. (PKI) owns ViaCell, a Cambridge, Massachusetts company which sells ViaCord, a product which is used to preserve baby's umbilical cord blood. They also research and other therapeutic uses of umbilical cord blood-derived and adult-derived stem cells. The stock has a PE of 17 and a yield of 1.7%.

Celgene (CELG) This New Jersey company is involved in the discovery, production, and marketing of therapies designed to treat cancer and immune-inflammatory-related diseases. They own LifeBank USA, a cord blood bank. The P/E is 74.

Baxter International Inc. (BAX) makes blood collection bags for umbilical cord blood and develop adult stem-cell therapies. They also own a patent for assembling and methods to process cord blood in a sterile fashion to avoid exposure to bacterial contamination and to meter the introduction of cryopreservation solution into cord blood at a desired rate, thereby avoiding damage or trauma to the cord blood cells. The stock has a PE ratio of 14 and pays a yield of 2.1%.

Amgen Inc. (AMGN) is also funding research into cord blood extraction, preservation, and storage. The stock has a PE of 13.

For a free downloadable Excel database of cord blood and stem cell stocks, go to WallStreetNewsNetwork.com.

Author does not own any of the above.